MEDICARE PART D COST SHARING AND SPECIALTY DRUG INITIATION IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA PATIENTS

被引：0
|
作者：
Doshi, J. A. [1 ]
Li, P. [1 ]
Huo, H. [1 ]
Pettit, A. R. [1 ]
Kumar, R. [1 ]
Huntington, S. F. [2 ]
Weiss, B. M. [3 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Yale Univ, New Haven, CT USA
[3] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.035
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
ME2
引用
收藏
页码：A3 / A3
页数：1
相关论文
共 50 条
  • [1] High Cost Sharing and Specialty Drug Initiation Under Medicare Part D: A Case Study in Patients With Newly Diagnosed Chronic Myeloid Leukemia
    Doshi, Jalpa A.
    Li, Pengxiang
    Huo, Hairong
    Pettit, Amy R.
    Kumar, Rishab
    Weiss, Brendan M.
    Huntington, Scott F.
    AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 (04): : S78 - +
  • [2] Tyrosine Kinase Inhibitors Initiation, Cost Sharing, and Health Care Utilization in Patients with Newly Diagnosed Chronic Myeloid Leukemia: A Retrospective Claims-Based Study
    Phuar, Hsiao Ling
    Begley, Charles E.
    Chan, Wenyaw
    Krause, Trudy Millard
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (10): : 1140 - 1150
  • [3] Is imatinib a cost-effective treatment for newly diagnosed chronic myeloid leukemia patients?
    John Goldman
    Nature Clinical Practice Oncology, 2005, 2 : 126 - 127
  • [4] Is imatinib a cost-effective treatment for newly diagnosed chronic myeloid leukemia patients?
    Goldman, J
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (03): : 126 - 127
  • [5] Cost-sharing and financial burden for Medicare patients with newly diagnosed cancer
    Narang, Amol
    Nicholas, Lauren
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Imatinib Mesylate in Newly Diagnosed Patients of Chronic Myeloid Leukemia
    Jacob, L. Abraham
    Bapsy, P. P.
    Babu, K. Govind
    Lokanatha
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 20 - 25
  • [7] Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
    Gambacorti-Passerini, Carlo
    Piazza, Rocco
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (23): : 2274 - 2276
  • [8] Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
    Hochhaus, Andreas
    Wang, Jianxiang
    Kim, Dong-Wook
    Kim, Dennis Dong Hwan
    Mayer, Jiri
    Goh, Yeow-Tee
    le Coutre, Philipp
    Takahashi, Naoto
    Kim, Inho
    Etienne, Gabriel
    Andorsky, David
    Issa, Ghayas C.
    Larson, Richard A.
    Bombaci, Felice
    Kapoor, Shruti
    McCulloch, Tracey
    Malek, Kamel
    Yau, Lillian
    Ifrah, Sophie
    Hoch, Matthias
    Cortes, Jorge E.
    Hughes, Timothy P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (10): : 885 - 898
  • [9] How patient cost sharing of tyrosine kinase inhibitors affects initiation, adherence, and outcomes in patients with newly diagnosed chronic myeloid leukemia: A retrospective claims-based study
    Phuar, Hsiao Ling
    Begley, Charles E.
    Krause, Trudy M.
    Chan, Wenyaw
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (06)
  • [10] Asciminib in Newly Diagnosed Chronic Myeloid Leukemia
    Hochhaus, Andreas
    Wang, Jianxiang
    Kim, Dong-Wook
    Kim, Dennis Dong Hwan
    Mayer, Jiri
    Goh, Yeow-Tee
    le Coutre, Philipp
    Takahashi, Naoto
    Kim, Inho
    Etienne, Gabriel
    Andorsky, David
    Issa, Ghayas C.
    Larson, Richard A.
    Bombaci, Felice
    Kapoor, Shruti
    McCulloch, Tracey
    Malek, Kamel
    Yau, Lillian
    Ifrah, Sophie
    Hoch, Matthias
    Cortes, Jorge E.
    Hughes, Timothy P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024,
12345